A detailed history of Vista Capital Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vista Capital Partners, Inc. holds 1,576 shares of LLY stock, worth $1.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,576
Previous 1,719 8.32%
Holding current value
$1.28 Million
Previous $1.52 Million 20.11%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$727.2 - $932.06 $103,989 - $133,284
-143 Reduced 8.32%
1,576 $1.22 Million
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $501,891 - $624,013
650 Added 60.8%
1,719 $1.52 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $42,042 - $52,724
58 Added 5.74%
1,069 $967,000
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $530,967 - $625,940
1,011 New
1,011 $589,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $770B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vista Capital Partners, Inc. Portfolio

Follow Vista Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vista Capital Partners, Inc. with notifications on news.